Yutaka Ogihara
Presidente en KYORIN PHARMACEUTICAL CO., LTD. .
Fortuna: 826 951 $ al 30/04/2024
Perfil
Yutaka Ogihara is currently the President & Representative Director at KYORIN Pharmaceutical Co., Ltd.
He previously served as the Director & Head-Information System at KYORIN Pharmaceutical Co. Ltd.
(old) from 2014 to 2016.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
08/02/2024 | 70 763 ( 0.11% ) | 826 951 $ | 30/04/2024 |
Cargos activos de Yutaka Ogihara
Empresas | Cargo | Inicio |
---|---|---|
KYORIN PHARMACEUTICAL CO., LTD. | Presidente | 01/06/2019 |
Antiguos cargos conocidos de Yutaka Ogihara.
Empresas | Cargo | Fin |
---|---|---|
KYORIN Pharmaceutical Co. Ltd. (old)
KYORIN Pharmaceutical Co. Ltd. (old) Pharmaceuticals: MajorHealth Technology KYORIN Pharmaceutical Co., Ltd. develops and supplies prescription medicines. Its primary drugs include antibacterial tablets, asthma tablets, gastric ulcer agents and mucoregulants. The company was founded in 1923 and is headquartered in Tokyo, Japan. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
KYORIN PHARMACEUTICAL CO., LTD. | Health Technology |
Empresas privadas | 1 |
---|---|
KYORIN Pharmaceutical Co. Ltd. (old)
KYORIN Pharmaceutical Co. Ltd. (old) Pharmaceuticals: MajorHealth Technology KYORIN Pharmaceutical Co., Ltd. develops and supplies prescription medicines. Its primary drugs include antibacterial tablets, asthma tablets, gastric ulcer agents and mucoregulants. The company was founded in 1923 and is headquartered in Tokyo, Japan. | Health Technology |
- Bolsa de valores
- Insiders
- Yutaka Ogihara